GFAP and nervous system disorder: Several CSF molecules have been proposed as reliable markers for glial cell activation within CNS, potentially reflecting the involvement of astrogliosis (i.e. GFAP) and microgliosis (i.e. soluble TREM2) in the pathogenesis of neurological disorders (Gaetani et al., 2020; Gao et al., 2023).